胎儿镜与开放式脊髓脊膜膨出修补的两胎次成本效果分析
本研究采用决策分析模型,假设500名计划再次妊娠的脊髓脊膜膨出胎儿孕妇,比较胎儿镜与开放式修补的成本与结局。胎儿镜组虽成本更高,但在本次及后续妊娠中均减少早产、死胎及神经发育 disability,增量成本效果比为每质量调整生命年1029美元,概率敏感性分析显示100%具有成本效果。
要点
- 胎儿镜修补虽成本更高,但每QALY增量成本仅1029美元,低于10万美元支付意愿阈值。
- 胎儿镜组本次妊娠早产减少140例,神经发育 disability 和新生儿死亡也更少。
- 后续妊娠中胎儿镜组减少22例分娩并发症、24例死胎和22例早产。
核心结论
- 在计划再次妊娠的理论队列中,胎儿镜修补虽成本更高,但改善母儿结局并具有成本效果。
研究设计与样本
- 决策分析模型(TreeAge软件),假设500名产前诊断脊髓脊膜膨出且计划未来妊娠的孕妇,比较胎儿镜与开放式修补。
主要发现
- 本次妊娠胎儿镜组早产减少140例,神经发育 disability 和新生儿死亡也更少。
- 本次妊娠胎儿镜组功能水平优于解剖水平>2级者增加130例,差于解剖水平>2级者减少35例,功能相同者减少107例。
- 后续妊娠胎儿镜组分娩并发症(子宫裂开、破裂、大出血)减少22例,死胎减少24例,早产减少22例。
- 增量成本效果比为每质量调整生命年1029美元,蒙特卡洛概率敏感性分析显示胎儿镜技术100%具有成本效果。
关键数值与推荐
- 支付意愿阈值设为每质量调整生命年100,000美元。
- 模型计算孕妇、脊髓脊膜膨出新生儿及后续妊娠新生儿的成本与质量调整生命年。
临床怎么用
- 对于计划再次妊娠的脊髓脊膜膨出胎儿孕妇,胎儿镜修补可能作为兼顾本次与后续妊娠结局的成本效果选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent studies have compared maternal and neonatal outcomes associated with fetoscopic surgical approach for repair of myelomeningocele compared with an open approach. OBJECTIVE: In this study, we compared the cost-effectiveness of these techniques in the setting of a woman seeking future pregnancies. STUDY DESIGN: A decision-analytical model using TreeAge software was designed to compare the costs and outcomes of fetoscopic vs open repair in patients with prenatally diagnosed myelomeningocele. We assumed a theoretical cohort of 500 women with a pregnancy affected by myelomeningocele planning to have a future pregnancy. Our model accounted for costs and quality-adjusted life years of the woman, the neonate with myelomeningocele, and the neonate in a subsequent pregnancy. Neonatal outcomes from the incident pregnancy included motor function >2 levels better than the anatomic level, motor function <2 levels better than the anatomic level, and same motor function as the anatomic level, preterm birth in the index pregnancy, neonatal death in the index pregnancy, and major neurodevelopmental disability as a result of preterm birth in the index pregnancy. Neonatal outcomes in the subsequent pregnancy included stillbirth, preterm birth, and neonatal and major neurodevelopmental disability as a result of preterm birth. Probabilities were derived from the literature, and we used a willingness-to-pay threshold of $100,000 per quality-adjusted life year. RESULTS: In the index pregnancy, fetoscopic surgical technique resulted in 140 fewer cases of preterm birth and fewer cases of neurodevelopmental disability and neonatal death. Fetoscopic technique resulted in 130 more cases of functional level >2 levels better than the anatomic level, 35 fewer cases of functional level >2 levels worse than the anatomic level, and 107 fewer cases of function same as the anatomic level. In the subsequent pregnancy, fetoscopic surgery led to 22 fewer cases of delivery complications (uterine dehiscence, uterine rupture, and excessive bleeding), 24 fewer cases of stillbirth, and 22 fewer cases of preterm birth. Although the fetoscopic approach was more costly, it was cost-effective with an incremental cost-effectiveness ratio of $1029 per quality-adjusted life year in our theoretical cohort of 500 patients. Monte Carlo probabilistic sensitivity analysis showed that fetoscopic technique is cost-effective 100% of the time. CONCLUSION: In our theoretical cohort, the fetoscopic approach was more costly, but resulted in improved outcomes when a subsequent pregnancy was considered.
引用
- Packer CH, Hersh AR, Caughey AB, et al. Fetoscopic compared with open repair of myelomeningocele: a 2-delivery cost-effectiveness analysis. Am J Obstet Gynecol MFM. 2021. PMID: 34217856. doi:10.1016/j.ajogmf.2021.100434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。